Hospira, Inc. (HSP) - NYSE
  • Feb. 13, 2013, 7:44 AM
    Hospira (HSP): Q4 EPS of $0.55 beats by $0.01. Revenue of $1.1B beats by $0.06B. (PR)
    | Feb. 13, 2013, 7:44 AM
  • Feb. 13, 2013, 12:05 AM

    Notable earnings before Wednesday’s open: ASPS, AVEO, CPN, DE, DF, DPS, DUK, EZCH, FBN, H, HSP, LO, PES, PRLB, TLM, TRI, VG, WCG, WFR

    | Feb. 13, 2013, 12:05 AM | 1 Comment
  • Feb. 12, 2013, 5:30 PM

    Notable earnings before Wednesday’s open: ASPS, AVEO, CPN, DE, DF, DPS, DUK, EZCH, FBN, H, HSP, LO, PES, PRLB, TLM, TRI, VG, WCG, WFR

    | Feb. 12, 2013, 5:30 PM
  • Nov. 7, 2012, 9:15 AM

    More on Hospira (HSP) Q3: swings to net profit of $1.2M from loss of $88.9M last year. Strong U.S. and EMEA sales of several of its specialty injectable pharmaceutical products offset the impact to supply of the Hospira's quality-improvement efforts. Continues to expect 2012 net sales of -1% to +2%, excluding the impact of forex. Forecasts adjusted EPS of $2, in line. (PR)

    | Nov. 7, 2012, 9:15 AM
  • Nov. 7, 2012, 7:39 AM
    Hospira (HSP): Q3 EPS of $0.47 beats by $0.02. Revenue of $994M (+1.8% Y/Y) beats by $9M. (PR)
    | Nov. 7, 2012, 7:39 AM
  • Nov. 7, 2012, 12:05 AM

    Notable earnings before Wednesday’s open: AES, AGU, ARIA, BDX, CLH, CNP, CTSH, CWH, DVN, ENB, FNP, GOLD, HFC, HSP, JRCC, LAMR, LEAP, M, MNTA, MPEL, NIHD, PRGO, SODA, SONS, STWD, TAP, THC, TICC, TWX, VICL, WFR, WLP, WRES

    | Nov. 7, 2012, 12:05 AM
  • Nov. 6, 2012, 5:30 PM

    Notable earnings before Wednesday’s open: AES, AGU, ARIA, BDX, CLH, CNP, CTSH, CWH, DVN, ENB, FNP, GOLD, HFC, HSP, JRCC, LAMR, LEAP, M, MNTA, MPEL, NIHD, PRGO, SODA, SONS, STWD, TAP, THC, TICC, TWX, VICL, WFR, WLP, WRES

    | Nov. 6, 2012, 5:30 PM
  • Aug. 28, 2012, 5:05 PM

    Hospira (HSP) receives a warning letter from the FDA related to an inspection of the Company’s La Aurora de Heredia, Costa Rica device manufacturing facility from April 16, 2012 through April 19, 2012. The Costa Rica site manufactures most of the Company’s infusion devices and sets. The Company is still in the process of evaluating what corrective actions are required to address the matters raised in the letter.

    | Aug. 28, 2012, 5:05 PM | 1 Comment
  • Aug. 1, 2012, 11:46 AM

    More on Hospira (HSP +6.2%) Q2: swings to net loss of $2.5M from a profit of $143.6M a year earlier, due to charges related to quality control and restructuring, lower sales, and higher costs. Expects FY EPS at lower end of estimate of $2-$2.30 vs. consensus of $2.11.

    | Aug. 1, 2012, 11:46 AM
  • Aug. 1, 2012, 8:46 AM
    Hospira (HSP): Q2 EPS of $0.51 beats by $0.02. Revenue of $1.03B (-2.9% Y/Y) beats by $16M. (PR)
    | Aug. 1, 2012, 8:46 AM
  • Jul. 16, 2012, 10:39 AM

    Hospira (HSP -0.85%) has issued a nationwide recall of four injectable cancer drugs, due to particles embedded in the glass at the neck of the vial. The possibility exists that the particles could become loose and enter the solutions, and cause injury. Hospira has blamed a supplier for the defect. (PR)

    | Jul. 16, 2012, 10:39 AM
  • May 14, 2012, 11:21 AM
    Shares of Hospira (HSP -1.4%) dip after the company announced a voluntary recall over the weekend of one lot of its Hydromorphone Injection due to two reported complaints of a single Carpuject containing more than the 1 mL labeled fill volume. Pain medications such as Hydromorphone have life-threatening consequences if overdosed.
    | May 14, 2012, 11:21 AM
  • May 1, 2012, 8:01 AM
    Hospira (HSP): Q1 EPS of $0.47 beats by $0.01. Revenue of $966M (-3.6% Y/Y) beats by $17M. (PR)
    | May 1, 2012, 8:01 AM
  • May 1, 2012, 12:05 AM

    Notable earnings before Tuesday’s open: ACI, ADM, ADP, AGCO, AMG, ARW, AVP, BDX, BIIB, BP, CCJ, CIE, CMI, DPZ, ECL, EMR, ENDP, FE, FWLT, HCP, HRS, HSP, HUN, LM, MLM, MMC, NI, PFE, PLD, SIRI, TLM, TRI, TRW, VLO, VPHM, WEC

    | May 1, 2012, 12:05 AM
  • Apr. 30, 2012, 5:30 PM

    Notable earnings before Tuesday’s open: ACI, ADM, ADP, AGCO, AMG, ARW, AVP, BDX, BIIB, BP, CCJ, CIE, CMI, DPZ, ECL, EMR, ENDP, FE, FWLT, HCP, HRS, HSP, HUN, LM, MLM, MMC, NI, PFE, PLD, SIRI , TLM, TRI, TRW, VLO, VPHM, WEC

    | Apr. 30, 2012, 5:30 PM
  • Mar. 20, 2012, 2:56 PM
    Hospira (HSP +0.6%) jumps on takeover chatter, with Sandoz - a unit of Novartis (NVS) - a rumored buyer.
    | Mar. 20, 2012, 2:56 PM
Company Description
Hospira Inc is aprovider of injectable drugs and infusion technologies. The Company's business segments areSpecialty Injectable Pharmaceuticals, Medication Management and Other Pharmaceuticals.
Sector: Healthcare
Industry: Drug Delivery & Accessories
Country: United States